Skip to main content
. Author manuscript; available in PMC: 2020 Jan 9.
Published in final edited form as: Compr Rev Food Sci Food Saf. 2019 May 8;18(4):1111–1134. doi: 10.1111/1541-4337.12448

Table 4.

Summary of preclinical studies associating MSG exposure with hepatic toxicity

Mode of administration Species MSG dosage/day Duration of administration
(days)
MSG effect (vs. control) Reference
Mixed with diet Wistar rats 0.04 mg/kg (n=8)
0.08 mg/kg (n=8)
42
  • Morphological changes: dilated central veins, cyto-architectural distortions of the hepatocytes, centrilobular hemorrhagic necrosis;

  • Biochemical changes: increase in total protein, albumin, aspartate transaminase, and alanine transaminase activities;

  • Changes were dose-dependent.

(Eweka et al., 2011)
Mixed with diet Adult male Rattus norvigicus 6 g/kg 45
  • Central veins dilations, severe cyto-architectural distortions of the hepatocytes, vacuolated cytoplasm, swollen mitochondria and vesiculated rough endoplasmic reticulum with picknotic nuclei;

  • Collagen deposition and connective tissue fiber impairment in the hepatocytes, together with severe reduction of mucopolysaccharide content;

  • Increase of the expression of ki-67 and p53 pro-apoptotic proteins in hepatocytes.

(El-Meghawry El-Kenawy et al., 2012)
Oral Male Wistar Rats 8 g/kg (n=6) 20
  • Increased lipid peroxides in liver, kidney, and serum;

  • Diminished reduced glutathione in serum, liver, and kidney;

  • Increased triglycerides, total cholesterol, urea;

  • Morphological changes in liver (central venous congestion, diffuse degeneration, necrosis of hepatocytes) and kidney (cortical tubular degeneration).

(Paul et al., 2012)
Oral Male Wistar Rats 0.6 g/kg (n=6) 10
  • Increased lipid peroxidation and the activities of glutathione-S-transferase, catalase, superoxide dismutase in the liver;

  • Decreased reduced glutathione level in the hepatocytes;

  • Increased activities of aspartate transaminase, alanine transaminase and gamma glutamyl transferase.

(Onyema et al., 2006)
Subcutaneous Newborn C57BL/6J male mice 4 g/kg (n=6) Single dose administration within 5 days of their birth Characteristic liver histopathology of nonalcoholic steatohepatitis. Metabolic syndrome-like features:
  • Increase in serum levels of insulin and cholesterol;

  • Microvesicular steatosis and inflammatory cell infiltration in the liver;

  • Enlarged adipocytes and crown-like structures in the epididymal fat;

  • Increased frequencies of monocytes and M1 macrophages in the liver and epididymal fat tissue;

(Takai et al., 2014)
Subcutaneous ICR male mice 2 g/kg (n=36) associated with unrestricted (n=18) or restricted dietary regimens (n=18) From birth to day 5 of life
  • Obesity, increased adiposity in the absence of hyperphagia, hyperinsulinemia;

  • Increase in triglycerides, LDL-chlesterol and alanine transaminase activity after 6 months for both groups. Reversible at month 12 for group receiving MSG and restricted dietary regimen;

  • After 6 months, major liver steatosis, but no fibrosis, for both MSG groups.

  • At 12 months of age, the MSG-unrestricted mice, but not those with restricted diet, had mild fibrosis with steatohepatitis and liver nodules.

(Fujimoto et al., 2014)
Intraperitoneal Male albino Wistar-Norwegian brown hybrid rats 4 g/kg 10
  • Significant increase of lipid peroxidation and of glutathione-S-transferase activity in liver, kidney, brain of rats;

  • Decrease of glutathione level in the liver, kidney and brain;

  • Increased catalase and superoxide dismutase activities in liver, decreased their activities in kidney and brain;

  • Increased activity of aspartate transaminase, alanine transaminase and gamma glutamyl transferase.

(Farombi & Onyema, 2006)